Exhibit
10.29.2


 


WARRANT


 


THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED,
HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE ACT
AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS,
AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.


 


Warrant
Certificate No.: A-1


 


Original
Issue Date: August 10, 2021


 


FOR
VALUE RECEIVED, Allied Integral United, Inc., a Delaware corporation that has an agreement with Superconductor Technologies Inc., a Delaware
corporation (the “Company”), hereby certifies that Sterling Select II Advisory LLC, a Delaware limited liability
company, or its registered assigns (the “Holder”) is entitled to purchase from the Company 500,000 (Five Hundred
Thousand) duly authorized, validly issued, fully paid and nonassessable shares of Common Stock at a purchase price per share
of $11.00 (subject to adjustment as provided herein, the “Exercise Price”), all subject to the terms,
conditions and adjustments set forth below in this Warrant. Certain capitalized terms used herein are defined in Section 1 hereof.


 


1.
Definitions. As used in this Warrant, the following terms have the respective meanings
set forth below:


 


“Aggregate
Exercise Price” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is
then being exercised pursuant to Section 3 hereof, multiplied by (b) the Exercise Price in effect as of the Exercise Date in accordance
with the terms of this Warrant.


 


“Board”
means the board of directors of the Company.


 


“Business
Day” means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of San Antonio, Texas
are authorized or obligated by law or executive order to close.


 


“Common
Stock” means the common stock, par value $0.001per share, of the Company, and any capital stock into which such Common Stock
shall have been converted, exchanged or reclassified following the date hereof.


 


“Common
Stock Deemed Outstanding” means, at any given time, the sum of (a) the number of shares of Common Stock actually outstanding
at such time, plus (b) the number of shares of Common Stock issuable upon exercise of Options actually outstanding at such time,
plus (c) the number of shares of Common Stock issuable upon conversion or exchange of Convertible Securities actually outstanding
at such time (treating as actually outstanding any Convertible Securities issuable upon exercise of Options actually outstanding at such
time), in each case, regardless of whether the Options or Convertible Securities are actually exercisable at such time; provided,
that Common Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or
any of its wholly-owned subsidiaries.


 









    	 



    	 



    

 


“Company”
has the meaning set forth in the preamble.


 


“Convertible
Securities” means any securities (directly or indirectly) convertible into or exchangeable for Common Stock, but excluding
Options.


 


“Excluded
Issuances” means any issuance or sale (or deemed issuance or sale in accordance with Section 4(d)) by the Company after the
Original Issue Date of:


 


(a)
shares of Common Stock issued upon the exercise of this Warrant;


 


(b)
shares of Common Stock (as such number of shares is equitably adjusted for subsequent stock splits, stock combinations, stock dividends
and recapitalizations) issued directly or upon the exercise of Options to directors, officers, employees, or consultants of the Company
in connection with their service as directors of the Company, their employment by the Company or their retention as consultants by the
Company, in each case authorized by the Board and issued pursuant to any compensation program of the Company or any of its subsidiaries
(including all such shares of Common Stock and Options outstanding prior to the Original Issue Date);


 


(c)
shares of Common Stock issued upon the conversion or exercise of Options (other than Options covered by clause (b) above) or Convertible
Securities issued at or prior to the Original Issue Date, provided that such securities are not amended after the date hereof
to increase the number of shares of Common Stock issuable thereunder or to lower the exercise or conversion price thereof;


 


(d)
shares of Common Stock, Options or Convertible Securities issued


 


(i)
to persons in connection with a joint venture, strategic alliance or other commercial relationship with such person (including persons
that are customers, suppliers and strategic partners of the Company) relating to the operation of the Company’s business and not
for the primary purpose of raising equity capital,


 


(ii)
in connection with a transaction in which the Company, directly or indirectly, acquires another business or its tangible or intangible
assets, or


 






    	2



    	 



    

 


(iii)
to lenders as equity kickers in connection with debt financings of the Company, in each case where such transactions have been approved
by the Board;


 


(e)
shares of Common Stock in an offering for cash for the account of the Company that is underwritten on a firm commitment basis and is
registered with the Securities and Exchange Commission under the Securities Act of 1933, as amended;


 


(f)
shares of Common Stock, Options or Convertible Securities issued to the lessor or vendor in any office lease or equipment lease or similar
equipment financing transaction in which the Company obtains the use of such office space or equipment for its business; or


 


(g)
shares of Common Stock, Options or Convertible Securities issued to:


 


(i)
any person providing an equity facility where the price of Common Stock issued is at a discount to the market price that will be at a
10% discount to the market and the facility size is $150mm available after the Company is listed on any US or non US stock exchange;
or


 


(ii)
any person that is a distributor or licensee or franchisee of any of the products or services of the Company or any of its subsidiaries;
or


 


(iii)
any person that is an Affiliate of the initial Holder of this Warrant issued primarily for services to be provided.


 


“Exercise
Date” means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in Section
3 shall have been satisfied at or prior to 5:00 p.m., New York City time, on a Business Day, including, without limitation, the receipt
by the Company of the Exercise Agreement, the Warrant and the Aggregate Exercise Price.


 


“Exercise
Agreement” has the meaning set forth in Section 3(a)(i).


 


“Exercise
Period” has the meaning set forth in Section 2.


 


“Exercise
Price” has the meaning set forth in the preamble.


 






    	3



    	 



    

 


“Fair
Market Value” means, as of any particular date: (a) the volume weighted average of the closing sales prices of the Common Stock
for such day on all securities exchanges on which the Common Stock may at the time be listed; (b) if there have been no sales of the
Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the Common Stock on all
such exchanges at the end of such day; (c) if on any such day the Common Stock is not listed on a domestic securities exchange, the closing
sales price of the Common Stock as quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association
for such day; or (d) if there have been no sales of the Common Stock on the OTC Bulletin Board, the Pink OTC Markets or similar quotation
system or association on such day, the average of the highest bid and lowest asked prices for the Common Stock quoted on the OTC Bulletin
Board, the Pink OTC Markets or similar quotation system or association at the end of such day; in each case, averaged over twenty (20)
consecutive Business Days ending on the Business Day immediately prior to the day as of which “Fair Market Value” is being
determined; provided, that if the Common Stock is listed on any domestic securities exchange, the term “Business Day”
as used in this sentence means Business Days on which such exchange is open for trading. If at any time the Common Stock is not listed
on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association,
the “Fair Market Value” of the Common Stock shall be the fair market value per share as determined jointly by the Board and
the Holder; provided, that if the Board and the Holder are unable to agree on the fair market value per share of the Common Stock
within a reasonable period of time (not to exceed 30 days from the Company’s receipt of the Exercise Agreement), such fair market
value shall be determined by a nationally recognized investment banking, accounting or valuation firm jointly selected by the Board and
the Holder/engaged by the Company). The determination of such firm shall be final and conclusive, and the fees and expenses of such valuation
firm shall be borne by the Company.


 


In
determining the Fair Market Value of the Common Stock, an orderly sale transaction between a willing buyer and a willing seller shall
be assumed, using valuation techniques then prevailing in the securities industry without regard to the lack of liquidity of the Common
Stock due to any restrictions (contractual or otherwise) applicable thereto or any discount for minority interests and assuming full
disclosure of all relevant information and a reasonable period of time for effectuating such sale and assuming the sale of all of the
issued and outstanding Common Stock (including fractional interests) calculated on a fully diluted basis to include the conversion or
exchange of all securities then outstanding that are convertible into or exchangeable for Common Stock and the exercise of all rights
and warrants then outstanding and exercisable to purchase shares of Common Stock or securities convertible into or exchangeable for shares
of Common Stock; provided, that such assumption shall not include those securities, rights and warrants (a) owned or held by or
for the account of the Company or any of its subsidiaries, or (b) convertible or exchangeable into Common Stock where the conversion,
exchange or exercise price per share is greater than the Fair Market Value.’


 


“Holder”
has the meaning set forth in the preamble.


 


“Options”
means any warrants or other rights or options to subscribe for or purchase Common Stock or Convertible Securities.


 


“Original
Issue Date” means August 10, 2021, provided that the right to purchase any shares of Common Stock under this Warrant are subject
to the consummation of the Specified Merger.


 






    	4



    	 



    

 


“Nasdaq”
means The NASDAQ Stock Market LLC.


 


“OTC
Bulletin Board” means the Financial Industry Regulatory Authority OTC Bulletin Board electronic inter-dealer quotation system.


 


“Person”
means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization
or government or department or agency thereof.


 


“Pink
OTC Markets” means the OTC Markets Group Inc. electronic inter-dealer quotation system, including OTCQX, OTCQB and OTC Pink.


 


“Specified
Merger” means the merger of the Company and the other parties thereto that is described by the Company in the registration
statement on Form S-4 (registration no. 333-256138).


 


“Warrant”
means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.


 


“Warrant
Shares” means the shares of Common Stock or other capital stock of the Company then purchasable upon exercise of this Warrant
in accordance with the terms of this Warrant.


 


2.
Term of Warrant. Subject to the terms and conditions hereof, at any time or from
time to time after the date of the closing of the Merger and prior to 5:00 p.m., New York City time, on August 31, 2024 or, if such day
is not a Business Day, on the next preceding Business Day (the “Exercise Period”), the Holder of this Warrant may
exercise this Warrant for all or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).


 


3.
Exercise of Warrant.


 


(a)
Exercise Procedure. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part
of the unexercised Warrant Shares, upon:


 


(i)
surrender of this Warrant to the Company at its then principal executive offices (or an indemnification undertaking with respect to this
Warrant in the case of its loss, theft or destruction), together with an Exercise Agreement in the form attached hereto as Exhibit
A (each, an “Exercise Agreement”), duly completed (including specifying the number of Warrant Shares to be purchased)
and executed; and


 


(ii)
payment to the Company of the Aggregate Exercise Price in accordance with Section 3(b).


 


(b)
Payment of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as expressed
in the Exercise Agreement, by delivery to the Company of a certified or official bank check payable to the order of the Company or by
wire transfer of immediately available funds to an account designated in writing by the Company, in the amount of such Aggregate Exercise
Price.


 






    	5



    	 



    

 


(c)
Delivery of Stock Certificates. Upon receipt by the Company of the Exercise Agreement, surrender of this Warrant and payment of the Aggregate
Exercise Price (in accordance with Section 3(a) hereof), the Company shall, as promptly as practicable, and in any event within Three
(3) Business Days thereafter, execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder a certificate or
certificates representing the Warrant Shares issuable upon such exercise, together with cash in lieu of any fraction of a share, as provided
in Section 3(d) hereof. The stock certificate or certificates so delivered shall be, to the extent possible, in such denomination or
denominations as the exercising Holder shall reasonably request in the Exercise Agreement and shall be registered in the name of the
Holder or, subject to compliance with Section 7 below, such other Person’s name as shall be designated in the Exercise Agreement.
This Warrant shall be deemed to have been exercised and such certificate or certificates of Warrant Shares shall be deemed to have been
issued, and the Holder or any other Person so designated to be named therein shall be deemed to have become a holder of record of such
Warrant Shares for all purposes, as of the Exercise Date.


 


(d)
Fractional Shares. The Company shall not be required to issue a fractional Warrant Share upon exercise of any Warrant. As to any fraction
of a Warrant Share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall pay to such Holder an
amount in cash (by delivery of a certified or official bank check or by wire transfer of immediately available funds) equal to the product
of (i) such fraction multiplied by (ii) the Fair Market Value of one Warrant Share on the Exercise Date.


 


(e)
Delivery of New Warrant. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised,
the Company shall, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued in accordance
with Section 3(c) hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and unexercised
Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.


 


(f)
Valid Issuance of Warrant and Warrant Shares; Payment of Taxes. With respect to the exercise of this warrant, the Company hereby represents,
covenants and agrees:


 


(i)
This Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized and
validly issued.


 


(ii)
All Warrant Shares issuable upon the exercise of this Warrant pursuant to the terms hereof shall be, upon issuance, and the Company shall
take all such actions as may be necessary or appropriate in order that such Warrant Shares are, validly issued, fully paid and non-assessable,
issued without violation of any preemptive or similar rights of any stockholder of the Company and free and clear of all taxes, liens
and charges.


 






    	6



    	 



    

 


(iii)
The Company shall take all such actions as may be necessary to ensure that all such Warrant Shares are issued without violation by the
Company of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which shares of
Common Stock or other securities constituting Warrant Shares may be listed at the time of such exercise (except for official notice of
issuance which shall be immediately delivered by the Company upon each such issuance).


 


(iv)
The Company shall use its commercially reasonable efforts to cause the Warrant Shares, immediately upon such exercise, to be listed on
any domestic securities exchange upon which shares of Common Stock or other securities constituting Warrant Shares are listed at the
time of such exercise.


 


(v)
The Company shall pay all expenses in connection with, and all taxes and other governmental charges that may be imposed with respect
to, the issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not be required
to pay any tax or governmental charge that may be imposed with respect to any applicable withholding or the issuance or delivery of the
Warrant Shares to any Person other than the Holder, and no such issuance or delivery shall be made unless and until the Person requesting
such issuance has paid to the Company the amount of any such tax, or has established to the satisfaction of the Company that such tax
has been paid.


 


(g)
Conditional Exercise. Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection
with a public offering or a sale of the Company (pursuant to a merger, sale of stock, or otherwise), such exercise may at the election
of the Holder be conditioned upon the consummation of such transaction, in which case such exercise shall not be deemed to be effective
until immediately prior to the consummation of such transaction.


 


(h)
Reservation of Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but
unissued Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant,
the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and the par value per Warrant Share shall at all times
be less than or equal to the applicable Exercise Price. The Company shall not increase the par value of any Warrant Shares receivable
upon the exercise of this Warrant above the Exercise Price then in effect, and shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this
Warrant.


 






    	7



    	 



    

 


4.
Adjustment to Exercise Price and Number of Warrant Shares. In order to prevent dilution
of the purchase rights granted under this Warrant, the Exercise Price and the number of Warrant Shares issuable upon exercise of this
Warrant shall be subject to adjustment from time to time as provided in this Section 4 (in each case, after taking into consideration
any prior adjustments pursuant to this Section 4).


 


(a)
Adjustment to Exercise Price Upon Issuance of Common Stock. Except as provided in Section 4(c) and except in the case of an event described
in either Section 4(e) or Section 4(f), if the Company shall, at any time or from time to time after the Original Issue Date, issue or
sell, or in accordance with Section 4(d) is deemed to have issued or sold, any shares of Common Stock without consideration or for consideration
per share less than the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale), then immediately
upon such issuance or sale (or deemed issuance or sale), the Exercise Price in effect immediately prior to such issuance or sale (or
deemed issuance or sale) shall be reduced (and in no event increased) to an Exercise Price equal to the quotient obtained by dividing:


 


(i)
the sum of (A) the product obtained by multiplying the Common Stock Deemed Outstanding immediately prior to such issuance or sale (or
deemed issuance or sale) by the Exercise Price then in effect plus (B) the aggregate consideration, if any, received by the Company upon
such issuance or sale (or deemed issuance or sale); by


 


(ii)
the sum of (A) the Common Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus (B) the
aggregate number of shares of Common Stock issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed
issuance or sale).


 


(b)
Adjustment to Number of Warrant Shares Upon Adjustment to Exercise Price. Upon any and each adjustment of the Exercise Price as provided
in Section 4(a), the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment shall
be increased to a number of Warrant Shares equal to the quotient obtained by dividing:


 


(i)
the product of (A) the Exercise Price in effect immediately prior to any such adjustment multiplied by (B) the number of Warrant Shares
issuable upon exercise of this Warrant immediately prior to any such adjustment; by


 


(ii)
the Exercise Price resulting from such adjustment.


 


(c)
Exceptions To Adjustment Upon Issuance of Common Stock. Anything herein to the contrary notwithstanding, there shall be no adjustment
to the Exercise Price or the number of Warrant Shares issuable upon exercise of this Warrant with respect to any Excluded Issuance.


 






    	8



    	 



    

 


(d)
Effect of Certain Events on Adjustment to Exercise Price. For purposes of determining the adjusted Exercise Price under Section 4(a)
hereof, the following shall be applicable:


 


(i)
Issuance of Options. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant or sell
(whether directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange
any Convertible Securities issuable upon the exercise of such Options are immediately exercisable, and the lowest price per share (determined
as provided in this paragraph and in Section 4(d)(v) ) for which any one share of Common Stock is issuable upon the exercise of any such
Option or upon the conversion or exchange of any Convertible Security issuable upon the exercise of any such Option is less than the
Exercise Price in effect immediately prior to the time of the granting or sale of such Options, then such share of Common Stock issuable
upon the exercise of such Option or upon conversion or exchange of such Convertible Security issuable upon the exercise of such Option
shall be deemed to have been issued as of the date of granting or sale of such Options (and thereafter shall be deemed to be outstanding
for purposes of adjusting the Exercise Price under Section 4(a)), at a price per share equal to such lowest price per share. For purposes
of this Section 4(d)(i) , the lowest price per share for which any one share of Common Stock is issuable upon the exercise of any such
Option or upon the conversion or exchange of any Convertible Security issuable upon the exercise of any such Option shall be equal to
the sum (which sum shall constitute the applicable consideration received for purposes of Section 4(a)) of the lowest amounts of consideration,
if any, received or receivable by the Company as consideration with respect to any one share of Common Stock upon each of (A) the granting
or sale of the Option, plus (B) the exercise of the Option, plus (C) in the case of an Option which relates to Convertible Securities,
the issuance or sale of the Convertible Security and the conversion or exchange of the Convertible Security. Except as otherwise provided
in Section 4(d)(iii), no further adjustment of the Exercise Price shall be made upon the actual issuance of Common Stock or of Convertible
Securities upon exercise of such Options or upon the actual issuance of Common Stock upon conversion or exchange of Convertible Securities
issuable upon the exercise of such Options.


 


(ii)
Issuance of Convertible Securities. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner
grant or sell (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert
or exchange any such Convertible Securities is immediately exercisable, and the lowest price per share (determined as provided in this
paragraph and in Section 4(d)(v) ) for which one share of Common Stock is issuable upon the conversion or exchange of any such Convertible
Securities is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Convertible Securities,
then such share of Common Stock issuable upon conversion or exchange of such Convertible Security shall be deemed to have been issued
as of the date of granting or sale of such Convertible Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting
the Exercise Price under Section 4(a)), at a price per share equal to such lowest price per share. For purposes of this Section 4(d)(ii),
the lowest price per share for which any one share of Common Stock is issuable upon the conversion or exchange of any such Convertible
Security shall be equal to the sum (which sum shall constitute the applicable consideration received for purposes of Section 4(a)) of
the lowest amounts of consideration, if any, received or receivable by the Company as consideration with respect to any one share of
Common Stock upon each of (A) the granting or sale of the Convertible Security, plus (B) the conversion or exchange of the Convertible
Security. Except as otherwise provided in Section 4(d)(iii), no further adjustment of the Exercise Price shall be made upon the actual
issuance of Common Stock upon conversion or exchange of such Convertible Securities or by reason of the issue or sale of Convertible
Securities upon exercise of any Options to purchase any such Convertible Securities for which adjustments of the Exercise Price have
been made pursuant to the other provisions of this Section 4(d).


 






    	9



    	 



    

 


(iii)
Change in Terms of Options or Convertible Securities. Upon any change in any of (A) the lowest amounts of consideration, if any, received
or receivable by the Company as consideration with respect to any one share of Common Stock upon the granting or sale of any Options
or Convertible Securities referred to in Section 4(d)(i) or Section 4(d)(ii) hereof, (B) the lowest amounts of additional consideration,
if any, payable to the Company with respect to any one share of Common Stock upon exercise of any Options or upon the issuance, conversion
or exchange of any Convertible Securities referred to in Section 4(d)(i) or Section 4(d)(ii) hereof, (C) the rate at which Convertible
Securities referred to in Section 4(d)(i) or Section 4(d)(ii) hereof are convertible into or exchangeable for Common Stock, or (D) the
maximum number of shares of Common Stock issuable in connection with any Options referred to in Section 4(d)(i) hereof or any Convertible
Securities referred to in Section 4(d)(ii) hereof (in each case, other than in connection with an Excluded Issuance), then (whether or
not the original issuance or sale of such Options or Convertible Securities resulted in an adjustment to the Exercise Price pursuant
to this Section 4) the Exercise Price in effect at the time of such change shall be adjusted or readjusted, as applicable, to the Exercise
Price which would have been in effect at such time pursuant to the provisions of this Section 4 had such Options or Convertible Securities
still outstanding provided for such changed consideration, conversion rate or maximum number of shares, as the case may be, at the time
initially granted, issued or sold, but only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced,
and the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment or readjustment
shall be correspondingly adjusted or readjusted pursuant to the provisions of Section 4(b).


 


(iv)
Treatment of Expired or Terminated Options or Convertible Securities. Upon the expiration or termination of any unexercised Option (or
portion thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its
original issuance or upon a revision of its terms) was made pursuant to this Section 4 (including without limitation upon the redemption
or purchase for consideration of all or any portion of such Option or Convertible Security by the Company), the Exercise Price then in
effect hereunder shall forthwith be changed pursuant to the provisions of this Section 4 to the Exercise Price which would have been
in effect at the time of such expiration or termination had such unexercised Option (or portion thereof) or unconverted or unexchanged
Convertible Security (or portion thereof), to the extent outstanding immediately prior to such expiration or termination, never been
issued.


 






    	10



    	 



    

 


(v)
Calculation of Consideration Received. If the Company shall, at any time or from time to time after the Original Issue Date, issue or
sell, or is deemed to have issued or sold in accordance with Section 4(d), any shares of Common Stock, Options or Convertible Securities:
(A) for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor; (B) for consideration
other than cash, the amount of the consideration other than cash received by the Company shall be the fair value of such consideration,
except where such consideration consists of marketable securities, in which case the amount of consideration received by the Company
shall be the market price (as reflected on any securities exchange, quotation system or association or similar pricing system covering
such security) for such securities as of the end of business on the date of receipt of such securities; (C) for no specifically allocated
consideration in connection with an issuance or sale of other securities of the Company, together comprising one integrated transaction,
the amount of the consideration therefor shall be deemed to be the fair value of such portion of the aggregate consideration received
by the Company in such transaction as is attributable to such shares of Common Stock, Options or Convertible Securities, as the case
may be, issued in such transaction/shall be deemed to be $0.01/shall be deemed to have been issued without consideration];
or (D) to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving corporation, the
amount of consideration therefor shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving
entity as is attributable to such shares of Common Stock, Options or Convertible Securities, as the case may be, issued to such owners.
The net amount of any cash consideration and the fair value of any consideration other than cash or marketable securities shall be determined
in good faith jointly by the Board and the Holder.


 


(vi)
Record Date. For purposes of any adjustment to the Exercise Price or the number of Warrant Shares in accordance with this Section 4,
in case the Company shall take a record of the holders of its Common Stock for the purpose of entitling them (A) to receive a dividend
or other distribution payable in Common Stock, Options or Convertible Securities or (B) to subscribe for or purchase Common Stock, Options
or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed
to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting
of such right of subscription or purchase, as the case may be; provided, that if before the distribution to its holders of Common
Stock the Company legally abandons its plan to pay or deliver such dividend, distribution, subscription or purchase rights, then thereafter
no adjustment shall be required by the taking of such record and any such adjustment previously made in respect thereof shall be rescinded
and annulled.


 






    	11



    	 



    

 


(vii)
Treasury Shares. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for
the account of the Company or any of its wholly-owned subsidiaries, and the disposition of any such shares (other than the cancellation
or retirement thereof or the transfer of such shares among the Company and its wholly-owned subsidiaries) shall be considered an issue
or sale of Common Stock for the purpose of this Section 4.


 


(viii)
Other Dividends and Distributions. Subject to the provisions of this Section 4(d), if the Company shall, at any time or from time to
time after the Original Issue Date, make or declare, or fix a record date for the determination of holders of Common Stock entitled to
receive, a dividend or any other distribution payable in securities of the Company (other than a dividend or distribution of shares of
Common Stock, Options or Convertible Securities in respect of outstanding shares of Common Stock), cash or other property, then, and
in each such event, provision shall be made so that the Holder shall receive upon exercise of the Warrant, in addition to the number
of Warrant Shares receivable thereupon, the kind and amount of securities of the Company, cash or other property which the Holder would
have been entitled to receive had the Warrant been exercised in full into Warrant Shares on the date of such event and had the Holder
thereafter, during the period from the date of such event to and including the Exercise Date, retained such securities, cash or other
property receivable by them as aforesaid during such period, giving application to all adjustments called for during such period under
this Section 4 with respect to the rights of the Holder; provided, that no such provision shall be made if the Holder receives,
simultaneously with the distribution to the holders of Common Stock, a dividend or other distribution of such securities, cash or other
property in an amount equal to the amount of such securities, cash or other property as the Holder would have received if the Warrant
had been exercised in full into Warrant Shares on the date of such event.


 


(e)
Adjustment to Exercise Price and Warrant Shares Upon Dividend, Subdivision or Combination of Common Stock. If the Company shall, at any
time or from time to time after the Original Issue Date, (i) pay a dividend or make any other distribution upon the Common Stock or any
other capital stock of the Company payable in shares of Common Stock or in Options or Convertible Securities, or (ii) subdivide (by any
stock split, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price
in effect immediately prior to any such dividend, distribution or subdivision shall be proportionately reduced and the number of Warrant
Shares issuable upon exercise of this Warrant shall be proportionately increased. If the Company at any time combines (by combination,
reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect
immediately prior to such combination shall be proportionately increased and the number of Warrant Shares issuable upon exercise of this
Warrant shall be proportionately decreased. Any adjustment under this Section 4(e) shall become effective at the close of business on
the date the dividend, subdivision or combination becomes effective.


 






    	12



    	 



    

 


(f)
Adjustment to Exercise Price and Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any (i)
capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value or from par
value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of
shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially all of the Company’s
assets to another Person or (v) other similar transaction (other than any such transaction covered by Section 4(e)), in each case which
entitles the holders of Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect
to or in exchange for Common Stock, each Warrant shall, immediately after such reorganization, reclassification, consolidation, merger,
sale or similar transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of
Warrant Shares then exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or
assets of the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon such
reorganization, reclassification, consolidation, merger, sale or similar transaction if the Holder had exercised this Warrant in full
immediately prior to the time of such reorganization, reclassification, consolidation, merger, sale or similar transaction and acquired
the applicable number of Warrant Shares then issuable hereunder as a result of such exercise (without taking into account any limitations
or restrictions on the exercisability of this Warrant); and, in such case, appropriate adjustment (in form and substance satisfactory
to the Holder) shall be made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section
4 hereof shall thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets
thereafter acquirable upon exercise of this Warrant (including, in the case of any consolidation, merger, sale or similar transaction
in which the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per
share for the Common Stock reflected by the terms of such consolidation, merger, sale or similar transaction, and a corresponding immediate
adjustment to the number of Warrant Shares acquirable upon exercise of this Warrant without regard to any limitations or restrictions
on exercise, if the value so reflected is less than the Exercise Price in effect immediately prior to such consolidation, merger, sale
or similar transaction). The provisions of this Section 4(f) shall similarly apply to successive reorganizations, reclassifications,
consolidations, mergers, sales or similar transactions. The Company shall not effect any such reorganization, reclassification, consolidation,
merger, sale or similar transaction unless, prior to the consummation thereof, the successor Person (if other than the Company) resulting
from such reorganization, reclassification, consolidation, merger, sale or similar transaction, shall assume, by written instrument substantially
similar in form and substance to this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such shares of
stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall be entitled to receive upon exercise
of this Warrant. Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction
contemplated by the provisions of this Section 4(f), the Holder shall have the right to elect prior to the consummation of such event
or transaction, to give effect to the exercise rights contained in Section 2 instead of giving effect to the provisions contained in
this Section 4(f) with respect to this Warrant.


 






    	13



    	 



    

 


(g)
Certain Events. If any event of the type contemplated by the provisions of this Section 4 but not expressly provided for by such provisions
(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features)
occurs, then the Board shall make an appropriate adjustment in the Exercise Price and the number of Warrant Shares issuable upon exercise
of this Warrant so as to protect the rights of the Holder in a manner consistent with the provisions of this Section 4; provided,
that no such adjustment pursuant to this Section 4(g) shall increase the Exercise Price or decrease the number of Warrant Shares issuable
as otherwise determined pursuant to this Section 4.


 


(h)
Certificate as to Adjustment.


 


(i)
As promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not later than twenty (20) Business
Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such
adjustment and the facts upon which it is based and certifying the calculation thereof.


 


(ii)
As promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later
than twenty (20) Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying the
Exercise Price then in effect and the number of Warrant Shares or the amount, if any, of other shares of stock, securities or assets
then issuable upon exercise of the Warrant.


 


(i)
Notices. In the event:


 


(i)
that the Company shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon
exercise of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, to vote at a meeting
(or by written consent), to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities,
or to receive any other security; or


 


(ii)
of any capital reorganization of the Company, any reclassification of the Common Stock of the Company, any consolidation or merger of
the Company with or into another Person, or sale of all or substantially all of the Company’s assets to another Person; or


 






    	14



    	 



    

 


(iii)
of the voluntary or involuntary dissolution, liquidation or winding-up of the Company;


 


then,
and in each such case, the Company shall send or cause to be sent to the Holder at least five (5) Business Days prior to the applicable
record date or the applicable expected effective date, as the case may be, for the event, a written notice specifying, as the case may
be, (A) the record date for such dividend, distribution, meeting or consent or other right or action, and a description of such dividend,
distribution or other right or action to be taken at such meeting or by written consent, or (B) the effective date on which such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up is proposed to take place, and the date, if any
is to be fixed, as of which the books of the Company shall close or a record shall be taken with respect to which the holders of record
of Common Stock (or such other capital stock or securities at the time issuable upon exercise of the Warrant) shall be entitled to exchange
their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, and the amount per share and character of such
exchange applicable to the Warrant and the Warrant Shares.


 


5.
Purchase Rights. In addition to any adjustments pursuant to Section 4 above, if at
any time the Company grants, issues or sells any shares of Common Stock, Options, Convertible Securities or rights to purchase stock,
warrants, securities or other property pro rata to the record holders of Common Stock (the “Purchase Rights”), then
the Holder shall be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder
would have acquired if the Holder had held the number of Warrant Shares acquirable upon complete exercise of this Warrant immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. Anything
herein to the contrary notwithstanding, the Holder shall not be entitled to the Purchase Rights granted herein with respect to any Excluded
Issuance.


 


6.
Not Subject to Any Stockholders Agreement. This Warrant and all Warrant Shares issuable
upon exercise of this Warrant are not subject to any stockholders agreement.


 


7.
Transfer of Warrant. Subject to the transfer conditions referred to in the legend
endorsed hereon, this Warrant and all rights hereunder are transferable, in whole or in part, by the Holder without charge to the Holder,
upon surrender of this Warrant to the Company at its then principal executive offices with a properly completed and duly executed Assignment
in the form attached hereto as Exhibit B, together with funds sufficient to pay any transfer taxes described in Section 3(f)(v)
in connection with the making of such transfer. Upon such compliance, surrender and delivery and, if required, such payment, the Company
shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such
instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned
and this Warrant shall promptly be cancelled.


 






    	15



    	 



    

 


8.
Holder Not Deemed a Stockholder; Limitations on Liability. Except as otherwise specifically
provided herein (including Section 4(d)(viii)) prior to the issuance to the Holder of the Warrant Shares to which the Holder is then
entitled to receive upon the due exercise of this Warrant, the Holder shall not be entitled to vote or receive dividends or be deemed
the holder of shares of capital stock of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer
upon the Holder, as such, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate
action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive
notice of meetings, receive dividends or subscription rights, or otherwise. In addition, nothing contained in this Warrant shall be construed
as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder
of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 8,
the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally,
contemporaneously with the giving thereof to the stockholders.


 


9.
Replacement on Loss; Division and Combination.


 


(a)
Replacement of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement
or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation
to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and
exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that,
in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.


 


(b)
Division and Combination of Warrant. Subject to compliance with the applicable provisions of this Warrant as to any transfer or other
assignment which may be involved in such division or combination, this Warrant may be divided or, following any such division of this
Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then principal
executive offices, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed
by the respective Holders or their agents or attorneys. Subject to compliance with the applicable provisions of this Warrant as to any
transfer or assignment which may be involved in such division or combination, the Company shall at its own expense execute and deliver
a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance with such notice. Such new Warrant or
Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable in the aggregate for an equivalent number
of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.


 


10.
No Impairment. The Company shall not, by amendment of its Certificate of Incorporation
or Bylaws, or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed by it hereunder,
but shall at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action
as may reasonably be requested by the Holder in order to protect the exercise rights of the Holder against dilution or other impairment,
consistent with the tenor and purpose of this Warrant.


 






    	16



    	 



    

 


11.
Compliance with the Securities Act.


 


(a)
Agreement to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant, agrees to comply in all respects with
the provisions of this Section 11 and the restrictive legend requirements set forth on the face of this Warrant and further agrees that
such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise hereof except
under circumstances that will not result in a violation of the Securities Act of 1933, as amended (the “Securities Act”).
This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Securities Act) shall be stamped
or imprinted with a legend in substantially the following form:


 


“THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED,
HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE ACT
AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS,
AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”


 


(b)
Representations of the Holder. In connection with the issuance of this Warrant, the Holder specifically represents, as of the date hereof,
to the Company by acceptance of this Warrant as follows:


 


(i)
The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. The
Holder is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment for its own account and not
with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except
pursuant to sales registered or exempted under the Securities Act.


 


(ii)
The Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving
a public offering and that, under such laws and applicable regulations, such securities may be resold without registration under the
Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule 144 under the
Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act.


 






    	17



    	 



    

 


(iii)
The Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such knowledge
and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant
and the Warrant Shares. The Holder has had an opportunity to ask questions and receive answers from the Company regarding the terms and
conditions of the offering of the Warrant and the business, properties, prospects and financial condition of the Company.


 


12.
Warrant Register. The Company shall keep and properly maintain at its principal executive
offices books for the registration of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name
the Warrant is registered on such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice
to the contrary, except any assignment, division, combination or other transfer of the Warrant effected in accordance with the provisions
of this Warrant.


 


13.
Notices. All notices, requests, consents, claims, demands, waivers and other communications
hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt);
(b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by
facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and
on the next Business Day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified
or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses
indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this Section 13).


 


	If
    to the Company:	8800
                           Village Drive

                           Suite 106

                           San Antonio, Texas 78217

                           Email: as provided to the initial Holder

    Attention:
    Chief Executive Officer

	 	 
	If
    to the Holder:	111
        Great Neck Road

    Great
    Neck, NY 11021

    E-mail:
    as provided to the Company

     

    Attention:
    Managing Director



 






    	18



    	 



    

 


14.
Cumulative Remedies. Except to the extent expressly provided in Section 8 to the
contrary, the rights and remedies provided in this Warrant are cumulative and are not exclusive of, and are in addition to and not in
substitution for, any other rights or remedies available at law, in equity or otherwise.


 


15.
Equitable Relief. Each of the Company and the Holder acknowledges that a breach or
threatened breach by such party of any of its obligations under this Warrant would give rise to irreparable harm to the other party hereto
for which monetary damages would not be an adequate remedy and hereby agrees that in the event of a breach or a threatened breach by
such party of any such obligations, the other party hereto shall, in addition to any and all other rights and remedies that may be available
to it in respect of such breach, be entitled to equitable relief, including a restraining order, an injunction, specific performance
and any other relief that may be available from a court of competent jurisdiction.


 


16.
Entire Agreement. This Warrant constitutes the sole and entire agreement of the parties
to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and
agreements, both written and oral, with respect to such subject matter.


 


17.
Successor and Assigns. This Warrant and the rights evidenced hereby shall be binding
upon and shall inure to the benefit of the parties hereto and the successors of the Company and the successors and permitted assigns
of the Holder. Such successors and/or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder.


 


18.
No Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company
and the Holder and their respective successors and, in the case of the Holder, permitted assigns and nothing herein, express or implied,
is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under
or by reason of this Warrant.


 


19.
Headings. The headings in this Warrant are for reference only and shall not affect
the interpretation of this Warrant.


 


20.
Amendment and Modification; Waiver. Except as otherwise provided herein, this Warrant
may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by the Company or the
Holder of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving.
No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified
by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to
exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a
waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further
exercise thereof or the exercise of any other right, remedy, power or privilege.


 


21.
Severability. If any term or provision of this Warrant is invalid, illegal or unenforceable
in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Warrant or
invalidate or render unenforceable such term or provision in any other jurisdiction.


 






    	19



    	 



    

 


22.
Governing Law. This Warrant shall be governed by and construed in accordance with
the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State
of Delaware or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of
Delaware.


 


23.
Submission to Jurisdiction. Any legal suit, action or proceeding arising out of or
based upon this Warrant or the transactions contemplated hereby may be instituted in the federal courts of the United States of America
or the courts of the State of New York in each case located in the County of Nassau, and each party irrevocably submits to the exclusive
jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by certified
or registered mail to such party’s address set forth herein shall be effective service of process for any suit, action or other
proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit,
action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action
or proceeding brought in any such court has been brought in an inconvenient forum.


 


24.
Waiver of Jury Trial. Each party acknowledges and agrees that any controversy which
may arise under this Warrant is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally
waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Warrant or the transactions
contemplated hereby.


 


25.
Counterparts. This Warrant may be executed in counterparts, each of which shall be
deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered
by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original
signed copy of this Warrant.


 


26.
No Strict Construction. This Warrant shall be construed without regard to any presumption
or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.


 


27.
Condition to Effectiveness. The terms and provisions of this Warrant shall be void ab initio if the Specified Merger is not closed
on or prior to September 30, 2021.


 


[signature
page follows]


 






    	20



    	 



    

 


IN
WITNESS WHEREOF, the Company has duly executed this Warrant on the Original Issue Date.


 


	 	Clearday,
    Inc.
	 	 	 
	 	By:	/s/
    James Walesa
	 	Name:	James
    Walesa
	 	Title:	CEO


 


	Accepted
    and agreed,	 
	 	 
	Sterling
    Select II Advisory LLC	 
	 	 	 
	By:	/s/
    Christopher J. Steele	 
	Name:	Christopher
    J. Steele	 
	Title:	Managing
    Director	 


 






    	21